Reprieve Cardiovascular
Developer of an acute decompensated heart failure (ADHF) treatment medical device designed to help patients experience life without limits. The company's device offers a proprietary method of diuretic...
Valuation
$100M
Market implied
Share Price
N/A
Total Raised
$103M
Last Round
N/A